2OLOFSEN E, VANDORP E, TEPPEMA L, et al. Naloxone reversal of morphine- and morphine-6-glucuronide-induced respiratory depression in healthy volunteers : a mechanism- based pharmacokinetic-pharmacodynamic modeling study [ J] .Anesthesiology, 2010, 112(6) : 1417-1427.
3COTTEN J F. TASK-1 ( KCNK3 ) and TASK-3 (KCNK9) tandem pore potassium channel antagonists stimulate breathing in isoflurane anesthetized rats[ J] .Anesth Analg, 2013,116(4) :810-816.
4MCCARTNEY C E, MCCLAFFERTY H, HUIBANT J M, et al. A cysteine-rich motif confers hypoxia sensitivity to mammalian large conductance voltage- and Ca-activated K (BK) channel ct-subunits [ J ]. Proc Natl Acad Sci, 2005, 102(49) : 17870-17876.
5GOLDER F J,HEW1TF M M, MCLEOD J F,et al.Respira- tory stimulant drugs in the post-operative setting [ J ]. Resp Physiol Neurobiol ,2013,189(2) :395-402.
6MCLEOD J F, LEEMPOELS J M, PENG S X, et al .GAL- 021, a new intravenous BKCa-channel blocker, is well tol- erated and stimulates ventilation in healthy volunteers [ J ]. Br J Anaesth,2014,113(5) :875-883.
7ROOZEKRANS M, VANDER SCHRIER R, OKKERSE P, et al.Two studies on reversal of opioid-induced respiratory depression by BK-channel blocker GAL021 in human vol- unteers [ J] .Anesthesiology, 2014,121 (3) :459-468.
